Showing results (101-110 of 279) with videos related to

Sort By:
Pageof 28
Journal of the National Comprehensive Cancer Network : JNCCN|March 12, 2025
Prognosis After Pathologic Complete Response to Neoadjuvant Therapy in Early-Stage Breast Cancer: A Population-Based StudyCaroline Boman, Christian Tranchell, Xingrong Liu, et al.
Statistical Methods in Medical Research|September 24, 2016
Feasibility of reusing time-matched controls in an overlapping cohortBénédicte Delcoigne, Niels Hagenbuch, Maria Ec Schelin, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|December 17, 2016
A prospective exploration of symptom burden clusters in women with breast cancer during chemotherapy treatmentMaria Browall, Yvonne Brandberg, Salmir Nasic, et al.
Molecular Oncology|April 19, 2015
Gene expression profiling of sequential metastatic biopsies for biomarker discovery in breast cancerTheodoros Foukakis, John Lövrot, Patricia Sandqvist, et al.
Clinical Epidemiology|April 14, 2011
Breast cancer associated with primary hyperparathyroidism: a nested case control studySophie Norenstedt, Fredrik Granath, Anders Ekbom, et al.
The Journal of Infection|April 12, 2016
Infection-related hospitalizations in breast cancer patients: Risk and impact on prognosisJudith S Brand, Edoardo Colzani, Anna L V Johansson, et al.
Clinical Breast Cancer|January 13, 2004
Prognostic correlation of basic fibroblast growth factor and vascular endothelial growth factor in 1307 primary breast cancersBarbro K Linderholm, Birgitta Lindh, Lars Beckman, et al.
Cancer|October 12, 2016
Time-dependent risk and predictors of venous thromboembolism in breast cancer patients: A population-based cohort studyJudith S Brand, Elham Hedayati, Nirmala Bhoo-Pathy, et al.
Seminars in Musculoskeletal Radiology|December 11, 2020
Interventional Techniques for Bone and Musculoskeletal Soft Tissue Tumors: Current Practices and Future Directions - Part I. AblationDanoob Dalili, Amanda Isaac, Alberto Bazzocchi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 10, 2006
Topoisomerase IIalpha gene amplification predicts favorable treatment response to tailored and dose-escalated anthracycline-based adjuvant chemotherapy in HER-2/neu-amplified breast cancer: Scandinavian Breast Group Trial 9401, Minna Tanner, Jorma Isola, et al.
Pageof 28